CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models
Antonelli, Roberta; Jiménez, Carlos; Riley, Misha; Servidei, Tiziana; Riccardi, Riccardo; Soriano, Aroa; Roma, Josep; Martinez-Saez, Elena; Martini, Maurizio; Ruggiero, Antonio; Moreno, Lucas; Sánchez de Toledo Codin, Josep; Gallego, Soledad; Bové, Jordi; Hooker, Jacob M.; Segura, Miguel F.; Universitat Autònoma de Barcelona
Pediatric ependymoma (EPN) is a highly aggressive tumor of the central nervous system that remains incurable in 40% of cases. In children, the majority of cases develop in the posterior fossa and can be classified into two distinct molecular entities: EPN posterior fossa A (PF-EPN-A) and EPN posterior fossa B (PF-EPN-B). Patients with PF-EPN-A have poor outcome and are in demand of new therapies. In general, PF-EPN-A tumors show a balanced chromosome copy number profile and have no recurrent somatic nucleotide variants. However, these tumors present abundant epigenetic deregulations, thereby suggesting that epigenetic therapies could provide new opportunities for PF-EPN-A patients. In vitro epigenetic drug screening of 11 compounds showed that histone deacetylase inhibitors (HDACi) had the highest anti-proliferative activity in two PF-EPN-A patient-derived cell lines. Further screening of 5 new brain-penetrating HDACi showed that CN133 induced apoptosis in vitro, reduced tumor growth in vivo and significantly extended the survival of mice with orthotopically-implanted EPN tumors by modulation of the unfolded protein response, PI3K/Akt/mTOR signaling, and apoptotic pathways among others. In summary, our results provide solid preclinical evidence for the use of CN133 as a new therapeutic agent against PF-EPN-A tumors
-Pediatric brain tumors
-Posterior fossa ependymoma
-Epigenetic therapies
-Histone deacetylase inhibitors (HDACi)
open access
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
https://creativecommons.org/licenses/by/4.0/
Article
         
https://ddd.uab.cat/record/252784

Show full item record

Related documents

Other documents of the same author

París-Coderch, Laia; Soriano, Aroa; Jiménez, Carlos; Erazo, Tatiana; Muñoz-Guardiola, Pau; Masanas, Marc; Antonelli, Roberta; Boloix, Ariadna; Alfón, José; Pérez-Montoyo, Héctor; Yeste-Velasco, Marc; Domènech, Carles; Roma, Josep; Sánchez de Toledo Codin, Josep; Moreno, Lucas; Lizcano de Vega, José Miguel; Gallego, Soledad; Segura, Miguel F.
Boloix, Ariadna; Masanas, Marc; Jiménez, Carlos; Antonelli, Roberta; Soriano, Aroa; Roma, Josep; Sánchez de Toledo, Josep; Gallego, Soledad; Segura, Miguel F.; Universitat Autònoma de Barcelona
Soriano, Aroa; Masanas, Marc; Boloix, Ariadna; Masiá, Núria; París-Coderch, Laia; Piskareva, Olga; Jiménez, Carlos; Henrich, Kai-Oliver; Roma, Josep; Westermann, Frank; Stallings, Raymond L.; Sábado, Constantino; de Toledo, Josep Sánchez; Santamaría, Anna; Gallego, Soledad; Segura, Miguel F.; Universitat Autònoma de Barcelona; Hospital Universitari Vall d'Hebron
Almazán-Moga, Anna; Zarzosa, Patricia; Vidal, Isaac; Molist, Carla; Giralt, Irina; Navarro, Natalia; Soriano, Aroa; Segura, Miguel F.; Alfranca, Arantza; Garcia-Castro, Javier; Sánchez de Toledo, José; Roma, Josep; Gallego, Soledad
Soriano, Aroa; París-Coderch, Laia; Jubierre Zapater, Luz; Martínez, Alba; Zhou, Xiangyu; Piskareva, Olga; Bray, Isabella; Vidal, Isaac; Almazán-Moga, Anna; Molist, Carla; Roma, Josep; Bayascas Ramírez, José Ramón.; Casanovas, Oriol; Stallings, Raymond L.; de Toledo, Josep Sánchez; Gallego, Soledad; Segura, Miguel F.; Universitat Autònoma de Barcelona. Vall d'Hebron Institut de Recerca (VHIR)
 

Coordination

 

Supporters